Hester Biosciences share price
You have to be logged in to add this to Watchlist.- ₹1,477.90(-0.28%)April 22, 2026 14:54:22 PM IST
- NSE
- BSE
- Vol : 6.70 K (NSE + BSE)Last 20 day avg : 5.22 K
Hester Biosciences is trading -0.28% lower at Rs 1,477.90 as compared to its last closing price. Hester Biosciences has been trading in the price range of 1,515.20 & 1,476.50. Hester Biosciences has given -6.11% in this year & 3.52% in the last 5 days. Hester Biosciences has TTM P/E ratio 42.45 as compared to the sector P/E of 43.60.The company posted a net profit of 8.77 Crores in its last quarter.Listed peers of Hester Biosciences include Sun Pharmaceutical Industries (0.26%), Cipla (0.17%), Divi's Laboratories (-0.29%).The Mutual Fund holding in Hester Biosciences was at 0.03% in 31 Dec 2022. The MF holding has decreased from the last quarter. The FII holding in Hester Biosciences was at 0.38% in 31 Mar 2026. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Apr 22, 2026, 09:12 PM UTC
- BetaHigh volatility1.43Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.68The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.47Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation-3.54The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Bearish | 1,669.50 | 0.26 | 4,00,451.32 | 36.24 | 5.77 | 0.92 | 0.50 |
| Cipla | Neutral | 1,235.00 | 0.17 | 99,785.44 | 22.95 | 3.87 | 0.87 | 0.81 |
| Divi's Laboratories | Neutral | 6,267.30 | -0.29 | 1,66,391.68 | 78.61 | 11.52 | 0.46 | 0.01 |
| Dr Reddy's Laboratories | Bearish | 1,216.60 | -0.34 | 1,01,602.04 | 18.63 | 3.14 | 0.63 | 2.34 |
| Torrent Pharmaceuticals | Neutral | 4,088.90 | -1.09 | 1,38,849.94 | 67.32 | 17.1 | 0.83 | 17.62 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-01-30 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-01 | Quarterly Results |
| 2025-05-09 | Audited Results & Final Dividend |
| 2025-01-30 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE782E01017
- BSE Code524669
- NSE CodeHESTERBIO
Hester Biosciences is trading at 1477.90 as on Wed Apr 22 2026 09:24:22. This is -0.28% lower as compared to its previous closing price of 1482.05.
The market capitalization of Hester Biosciences is 1258.12 Cr as on Wed Apr 22 2026 09:24:22.
The 52 wk high for Hester Biosciences is 2347.70 whereas the 52 wk low is 1250.95
Hester Biosciences can be analyzed on the following key metrics -
- TTM P/E: 42.45
- Sector P/E: 43.60
- Dividend Yield: 0.47%
- D/E ratio: -
Hester Biosciences reported a net profit of 27.49 Cr in 2025.
The Mutual Fund Shareholding was 0.03% at the end of 31 Dec 2022.
EQUITY QUICK LINKS
Hester Biosciences QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.